BioForm Medical, Inc. announced today that their dermal filler, RADIESSE, has sold more than 1.000.000 units worldwide since it was launched in 2002.

The dermal filler, RADIESSE, is used for aesthetic, reconstructive and therapeutic purposes. It has a strong safety profile, and is the only dermal filler on the market that has shown better aesthetic correction and higher patient satisfaction than Restylane and Juvederm, in peer-reviewed studies.

Read more


 

More news

(2011-12-21)
(2011-07-08)
(2011-02-28)
(2010-12-21)
(2010-11-30)
(2010-11-26)
(2010-11-22)
(2010-09-20)
(2010-06-17)
(2010-03-19)
(2009-08-21)
(2007-05-09)
 
 
News type
 
 

Latest PE Voice

Harald Mix on Nordic private equity

- 1/10/2012 10:10:00 AM
At the Argentum Conference in 2010, we asked Harald Mix, Managing Partner and Co-founder of Altor Equity Partners about the outlook for future returns in Nordic private equity.
 
 

Calendar

2012-02-16 in Bergen

Vestlandskonferansen

2012-02-27 in Berlin

SuperReturn International 2012

2012-03-05 in Copenhagen

Nordic Fundraising Summit

2012-03-14 in Geneva

EVCA Investors' Forum

2012-03-15 in La Clusaz

EVCA Networking Event 2012
 
Copyright Argentum 2009